Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.66 +0.01 (+1.71%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Operating Leases (2017 - 2024)

Updated

Biodexa Pharmaceuticals' Operating Leases came in at $229,747 for the quarter ended Dec 31, 2024, up 9.5% from $209,755 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Operating Leases (2017 - 2024) Analysis & Trends

As of Dec 31, 2024, Biodexa Pharmaceuticals' Operating Leases was $228,811, up 8.9% from the prior year.

  • Operating Leases carries a five-year compound annual growth rate of -5.1% (years ended Dec 2019 to Dec 2024).
  • Going back by year, Operating Leases was $210,206 in the year ended Dec 31, 2023 (+5.5%) and $199,255 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2024 represents the highest quarterly Operating Leases since the quarter ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 229,746.83
Dec 31, 2023 209,754.67
Dec 31, 2022 188,841.46
Dec 31, 2019 299,573.90
Dec 31, 2018 102,941.38
Dec 31, 2017 51,778.93
API Access

Biodexa Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BDRX&period=max&api_key=YOUR_API_KEY